| Dr Daniel C Lazowick, DO | |
|
100 E Lancaster Ave, 330 Lankenau Mob West, Wynnewood, PA 19096-3450 | |
| (610) 645-6555 | |
| (610) 649-4744 |
| Full Name | Dr Daniel C Lazowick |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 31 Years |
| Location | 100 E Lancaster Ave, Wynnewood, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063483527 | NPI | - | NPPES |
| 0016533330007 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | OS008535L (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | OS008535L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Main Line Health Homecare & Hospice - Hospice | Radnor, PA | Hospice |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Daniel C Lazowick Do Llc | 3870748130 | 2 |
News Archive
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
Imiquimod cream and photodynamic therapy for superficial basal cell carcinoma result in near equivalent rates of tumor-free survival after 1 year of treatment, a review shows.
The Science Coalition (TSC) strongly supports President Barack Obama's efforts to increase investment in basic research as a means to spur innovation and fuel the economy.
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
Reuters reports on the recent efforts by India's government to expand welfare programs throughout the country: "Since helping the Congress party win re-election last year, welfare has fast become the government's knee-jerk answer to policy dilemmas as it tries to ease food inflation, help growth trickle down to the poor, and win hearts and minds in" the country, the news service writes.
› Verified 8 days ago
| Entity Name | Daniel C Lazowick Do Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205175312 PECOS PAC ID: 3870748130 Enrollment ID: O20130313000145 |
News Archive
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
Imiquimod cream and photodynamic therapy for superficial basal cell carcinoma result in near equivalent rates of tumor-free survival after 1 year of treatment, a review shows.
The Science Coalition (TSC) strongly supports President Barack Obama's efforts to increase investment in basic research as a means to spur innovation and fuel the economy.
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
Reuters reports on the recent efforts by India's government to expand welfare programs throughout the country: "Since helping the Congress party win re-election last year, welfare has fast become the government's knee-jerk answer to policy dilemmas as it tries to ease food inflation, help growth trickle down to the poor, and win hearts and minds in" the country, the news service writes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel C Lazowick, DO 100 E Lancaster Ave Ste 461e, Wynnewood, PA 19096-3434 Ph: (610) 649-6100 | Dr Daniel C Lazowick, DO 100 E Lancaster Ave, 330 Lankenau Mob West, Wynnewood, PA 19096-3450 Ph: (610) 645-6555 |
News Archive
When combined with standard chemotherapy, an international Phase III trial has shown that the oral targeted therapy vandetanib improves progression-free survival for patients with advanced non-small cell lung cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
Imiquimod cream and photodynamic therapy for superficial basal cell carcinoma result in near equivalent rates of tumor-free survival after 1 year of treatment, a review shows.
The Science Coalition (TSC) strongly supports President Barack Obama's efforts to increase investment in basic research as a means to spur innovation and fuel the economy.
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
Reuters reports on the recent efforts by India's government to expand welfare programs throughout the country: "Since helping the Congress party win re-election last year, welfare has fast become the government's knee-jerk answer to policy dilemmas as it tries to ease food inflation, help growth trickle down to the poor, and win hearts and minds in" the country, the news service writes.
› Verified 8 days ago
Dr. Akhnuwkh Jones, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 610-645-2000 | |
Amanda B Christini, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Lancaster Ave, 4 Pavilion, Suite 4303, Wynnewood, PA 19096 Phone: 484-476-6421 Fax: 484-476-3149 | |
Daniel Wang, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, 4 Pavilion Ste 4303, Wynnewood, PA 19096 Phone: 484-476-6421 Fax: 484-476-3149 | |
Xiaoling Yu, Internal Medicine Medicare: Medicare Enrolled Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 484-476-6421 | |
Dr. Eric Marc Russell, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Wynnewood, PA 19096 Phone: 610-645-2000 | |
Dr. Jeremy Winthrop Gelber, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 Aubrey Rd, Wynnewood, PA 19096 Phone: 610-642-3999 | |
Dr. Scott Andrew Fink, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 E Lancaster Ave, Suite 252, Wynnewood, PA 19096 Phone: 610-896-7360 Fax: 610-896-5207 |